Navigation Links
DSM Biomedical to be Key Contributor at the Surfaces in Biomaterials Foundation's 2010 BioInterface Symposium and Workshop

BERKELEY, Calif., Oct. 7 /PRNewswire/ -- DSM Biomedical, a global leader in biomedical materials science, and its Berkeley based operation, DSM PTG, today announced the Company will be participating at the Surfaces in Biomaterials Foundation's 2010 BioInterface Symposium and Workshop, which will be held October 18 – 20 in Atlanta, Georgia.

With extensive experience in developing biomaterials for medical devices, the experts at DSM Biomedical will be discussing the latest industry developments. During an October 18th presentation, Jens Thies, Ph.D., business development manager and principal scientist at DSM Biomedical, will present his paper titled "DSM Non-Biofouling Coatings: A Stealth Approach to Fighting Biofilms", which explains how DSM has developed and marketed a variety of hydrophilic UV curable coatings. Further, CEO and president of DSM PTG, Bob Ward, will also discuss exciting applications under contract development by DSM that use biomaterials in a new role, specifically the treatment and prevention of infectious diseases.

"All of us at DSM are honored to be part of a prominent event that brings together world-class experts to discuss advances in the biomaterials industry," said Christophe Dardel, president of DSM Biomedical. "We have an extremely impressive line-up of speakers, all of whom bring their unique expertise and valuable insight to creating innovative solutions for material design and selection, synthesis and characterization, prototype fabrication and manufacturing of components and medical devices. This year's symposium and workshop promises to be exceptional."

Other experts from DSM who will be participating in the symposium and workshop include: Aylvin Dias, Principal Scientist, who is on the 2010 Program Committee and will be chairing the session titled, "Prevention of Biofilm Infections" on October 18, and Alessio Piermattei, Research Scientist, who will present a poster on October 19 on the use of antimicrobial coatings for Central Venous Catheters and prevention of biofilm infections.

To learn more about DSM Biomedical's participation at the event, or to register to attend the conference, go to

About DSM BiomedicalDSM Biomedical develops novel materials-based solutions to meet the present and future needs of the medical device and biopharmaceutical industries. Building on the expertise and strengths of DSM and its acquisition of The Polymer Technology Group, which is now known as DSM PTG, the company's product portfolio includes coatings, drug delivery platforms and a wide range of biomedical materials for use in short- and long-term implantable medical devices. Key product brands include Bionate® PCU and CarboSil® TSPCU, two of the most extensively tested biomedical polymers ever developed. Both polymers have excellent biostability, high strength and abrasion resistance, making them candidate materials for load-bearing orthopedic implants. ComfortCoat® hydrophilic and antimicrobial coating technology for catheters, guidewires and stent delivery systems; and Dyneema Purity®, a high-performance polyethylene fiber technology developed specifically for use in medical applications, such as orthopedic implants. The company also markets the Trancerta™ family of bioresorbable materials for drug delivery. This portfolio is based on DSM's core strengths in materials science combined with its extensive in-house library of synthesis methods, formulation and processing techniques. For more information, visit

DSM – the Life Sciences and Materials Sciences Company Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about 8 billion euro and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: For more information:Shivani MahtaniKwittken &

SOURCE DSM Biomedical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston University Biomedical Engineers Find Chink in Bacterias Armor
2. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
3. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
4. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
5. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
6. NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute
7. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
8. Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medicals Subsidiary, Sanvita, Inc.
9. Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research
10. Volcano Corporation Completes Acquisition of Lumen Biomedicals Xtract(TM) Thrombus Aspiration Catheter
11. Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International
Post Your Comments:
(Date:11/24/2015)... 24, 2015  DILON Diagnostics and GE Healthcare are ... for DILON to distribute GE,s Discovery NM750b Molecular Breast ... of this distribution agreement will provide Dilon,s experienced distribution ... system and is considered an initial step in an ... for clinicians and their patients. --> ...
(Date:11/24/2015)... COMMACK, N.Y. , Nov. 24, 2015 ... Pacemaker System, is pleased to announce the appointment of ... ... and pediatric cardiology at Children,s Hospital, Uppsala University, Uppsala ... . From 1984-1986, he was a fellow at the ...
(Date:11/24/2015)... BERN, Switzerland , November 24, 2015 ... for Biomedical Engineering Research of the University of ... Endocrinology, Diabetes and Clinical Nutrition of the Bern University ... an exclusive collaboration to develop a novel generation artificial ... personalised delivery of insulin for diabetic patients with the ...
Breaking Medicine Technology:
(Date:11/24/2015)... IN (PRWEB) , ... November 24, 2015 , ... ... benefits advisory organization, is pleased to welcome Winter-Dent & Company as its newest ... from day one to become a client's most trusted advisor regardless of whether ...
(Date:11/24/2015)... ... November 24, 2015 , ... Serenity Point Rehabilitation, a ... of recent video interviews with some of the staff members at their recovery center. ... treatment facility, as well as some of the things that make their recovery program ...
(Date:11/24/2015)... ... November 24, 2015 , ... Abington Hospital ... Aetna Institute of Quality® Bariatric Surgery Facility for treating individuals living with morbid ... health care services available to its members to help them make informed decisions ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... and Healthy Aging Program have announced their endorsement of the Medical Fitness ... Health Fitness is proud to have the MFN as one of our endorsed ...
(Date:11/24/2015)... ... November 24, 2015 , ... World Patent ... Blending, a household invention that revolutionizes the vending machine industry by providing healthy ... is worth $2 billion," says Scott Cooper, CEO and Creative Director of World ...
Breaking Medicine News(10 mins):